Preliminary result of accelerated partial breast irradiation after breast-conserving surgery

被引:20
作者
Yoshida, Ken [1 ]
Nose, Takayuki [2 ]
Masuda, Norikazu [3 ]
Yamazaki, Hideya [4 ]
Kotsuma, Tadayuki [1 ]
Yoshida, Mineo [1 ]
Yamamura, Jun [3 ]
Masuda, Hiroko [3 ]
Shin, Eisei [5 ]
Nakaba, Hiroyuki [6 ]
Komoike, Yoshifumi [7 ]
Tokuda, Yukiko [1 ]
Takeda, Masashi [8 ]
Kuriyama, Keiko [1 ]
机构
[1] Osaka Natl Hosp, Dept Radiol, Natl Hosp Org, Chuo Ku, Osaka 5400006, Japan
[2] Japanese Fdn Canc Res, Dept Radiat Oncol, Canc Inst Hosp, Tokyo, Japan
[3] Osaka Natl Hosp, Dept Surg, Natl Hosp Org, Osaka 5400006, Japan
[4] Kyoto Prefectural Univ Med, Dept Radiol, Kamigyo Ku, Kyoto, Japan
[5] Iseikai Hosp, Dept Breast Oncol, Osaka, Japan
[6] Otemae Hosp, Dept Surg, Osaka, Japan
[7] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan
[8] Osaka Natl Hosp, Dept Pathol, Natl Hosp Org, Osaka 5400006, Japan
关键词
APBI; Breast-conserving surgery; Wound complication; Japanese women; LOW-DOSE-RATE; INTERSTITIAL BRACHYTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; TUMOR-EXCISION; CANCER; LUMPECTOMY; TOXICITY; RADIOTHERAPY; EXPERIENCE;
D O I
10.1007/s12282-008-0067-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To investigate the feasibility of accelerated partial breast irradiation (APBI) for Japanese patients, we started high-dose-rate interstitial brachytherapy (HDR-ISBT) as monotherapy after breast-conserving surgery (BCS). Methods We implanted 45 Tis-2 breast cancer patients at National Hospital Organization Osaka National Hospital between June 2002 and June 2006. Our eligibility criteria were broader than the ones used previously in western countries. We included margin-positive cases and younger patients (median age: 44; range: 26-68) to adapt the criteria for Japanese women. Total prescribed doses were 36-42 Gy in six to seven fractions, and the volumes encompassed by 100% prescribed dose (V100) were 38.5-315.1 cc. Fifteen patients received chemotherapy. Results Treatment could be completed for all patients. Two local failures (4%) and two distant metastases were observed, while one patient died of liver metastasis. Seven wound complications, four with and three without infection, and two rib fractures occurred. The significant risk factors for wound complications were non-administration of prophylactic antibiotics during ISBT (P < 0.01), open cavity implant (P < 0.05), large V100 (P < 0.01), V150 (P < 0.05), and V200 (P < 0.05). Conclusion APBI after BCS for Japanese women with relatively small breasts was well tolerated, but special care should be taken with treatment technique.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 26 条
[1]   Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience [J].
Arthur, DW ;
Koo, D ;
Zwicker, RD ;
Tong, SD ;
Bear, HD ;
Kaplan, BJ ;
Kavanagh, BD ;
Warwicke, LA ;
Holdford, D ;
Amir, C ;
Archer, KJ ;
Schmidt-Ullrich, RK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (03) :681-689
[2]   The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy [J].
Baglan, KL ;
Martinez, AA ;
Frazier, RC ;
Kini, VR ;
Kestin, LL ;
Chen, PY ;
Edmundson, G ;
Mele, E ;
Jaffray, D ;
Vicini, FA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (04) :1003-1011
[3]   Partial breast irradiation in breast-conserving therapy by way of interstitial brachytherapy [J].
Benitez, PR ;
Chen, PY ;
Vicini, FA ;
Wallace, M ;
Kestin, L ;
Edmundson, G ;
Gustafson, G ;
Martinez, A .
AMERICAN JOURNAL OF SURGERY, 2004, 188 (04) :355-364
[4]   Long-term cosmetic results and toxicity after accelerated partial-breast irradiation - A method of radiation delivery by interstitial Brachytherapy for the treatment of early-stage breast carcinoma [J].
Chen, PY ;
Vicini, FA ;
Benitez, P ;
Kestin, LL ;
Wallace, M ;
Mitchell, C ;
Pettinga, J ;
Martinez, AA .
CANCER, 2006, 106 (05) :991-999
[5]  
Cuttino LW, 2006, ACCELERATED PARTIAL BREAST IRRADIATION: TECHNIQUES AND CLINICAL IMPLEMENTATION, P79, DOI 10.1007/3-540-28203-3_7
[6]   Inadequacy of iridium implant as sole radiation treatment for operable breast cancer [J].
Fentiman, IS ;
Poole, C ;
Tong, D ;
Winter, PJ ;
Gregory, WM ;
Mayles, HMO ;
Turner, P ;
Chaudary, MA ;
Rubens, RD .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (04) :608-611
[7]   Long-term results of wide field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer [J].
King, TA ;
Bolton, JS ;
Kuske, RR ;
Fuhrman, GM ;
Scroggins, TG ;
Jiang, XZ .
AMERICAN JOURNAL OF SURGERY, 2000, 180 (04) :299-304
[8]   Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: Retrospective analysis regarding failure patterns and factors influencing local control [J].
Kodaira, T ;
Fuwa, N ;
Itoh, Y ;
Matsumoto, A ;
Kamata, M ;
Furutani, K ;
Sasaoka, M ;
Miura, S ;
Takeuchi, T .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (05) :1311-1316
[9]   Long-term results of breast conserving surgery for stages i and II breast cancer: Experiences at osaka medical center for cancer and cardiovascular diseases [J].
Komoike Y. ;
Motomura K. ;
Inaji H. ;
Kasugai T. ;
Nose T. ;
Koizumi M. ;
Koyama H. .
Breast Cancer, 2002, 9 (3) :248-253
[10]   Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: Toxicity analysis of RTOG 95-17 [J].
Kuske, RR ;
Winter, K ;
Arthur, DW ;
Bolton, J ;
Rabinovitch, R ;
White, J ;
Hanson, W ;
Wilenzick, RM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01) :45-51